Duff reports on clinical trial safety
Experts have made 22 recommendations to improve the safety of Phase I drug trials after the disastrous trial that nearly killed six volunteers.
Archives for December 8, 2006
GSK invests in miniature antibodies
GlaxoSmithKline is adding to its investments in biopharmaceutical drug development through the acquisition of pioneering mini-antibody technology.
GM bacteria eats cancer
A genetically modified bacterium has been found to eat tumours and secrete a protein that opens up 'packaged' anti-cancer therapies.
PerkinElmer buys Evotec Technologies
PerkinElmer strengthens its position in the cell analysis instrumentation market by acquiring Evotec Technologies for approximately €23m.
Onyx fall away in race to find skin cancer drug
Onyx Pharmaceuticals have fallen out of the race to find a badly needed new treatment for skin cancer after their lead drug tripped up in its final stage clinical trial.